FDA Approved: IMBRUVICA — Original Application (Pharmacyclics LLC)

View source ↗

Summary

FDA approved IMBRUVICA (ibrutinib) under the Original Application (NDA210563) for mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• IMBRUVICA (IBRUTINIB)

Snippet

ORIG AP for IMBRUVICA (IBRUTINIB)